Skip to content
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•121 filings

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Net sales of $1.6M over the last 3 months

4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.

How to read this signal

Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.

JSON example

3-month balance

−$1,645,000

0 buyers · 4 sellers

12-month purchases

$0.00

0 distinct insiders

12-month sales

$3,942,269

6 distinct insiders

Highlighted alerts

8

22 Rule 10b5-1 trades treated as informational

Buying cluster · 30 days

Fewer than three distinct buyers

CEO/CFO purchases · 12 months

No executive purchases found

Get CLOV insider trades by API

The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.

Get your free API key

CLOV overview: breakout setup, X sentiment and insiders in one page →

Form 4 raw → Raspberry

The value is in what we do not call a signal.

The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.

100
Raw transactions
Everything returned by the filing
30
Voluntary view
P/S trades after deterministic checks
80
Administrative noise
Stored, never alerted
39
10b5-1
Shown as informational
SEC ownership XML facts
Code
S
Shares
62,176
Price
$4.68
Footnotes
2

The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Raspberry interpretation
Informational — no alert

Reason: tax_withholding. The filing footnotes identify tax withholding. The trade is reported under a Rule 10b5-1 plan.

Verify in SEC EDGAR

Recent transactions

Voluntary purchases and sales; administrative noise stays hidden.

30 transactions

Soares Karen

Chief Legal Officer

Sale 10b5-1
Shares
19,275
Price
$4.66
Value
$89,822
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
4,066
Price
$4.41
Value
$17,931
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
2,006
Price
$4.63
Value
$9,288
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
1,921
Price
$4.56
Value
$8,760
Open SEC filing

Wai Conrad

CEO, Counterpart Health

Sale 10b5-1
Shares
300,000
Price
$4.72
Value
$1,416,000
Open SEC filing

OLDAKOWSKI JOSEPH FRANK

VP OF FINANCE AND CONTROLLER

SaleAlert
Shares
20,000
Price
$5.16
Value
$103,200
Open SEC filing

Soares Karen

Chief Legal Officer

Sale 10b5-1
Shares
51,700
Price
$4.51
Value
$233,167
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
4,839
Price
$4.53
Value
$21,921
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
2,384
Price
$4.68
Value
$11,157
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
2,360
Price
$4.78
Value
$11,281
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
7,289
Price
$4.91
Value
$35,789
Open SEC filing

Wai Conrad

CEO, Counterpart Health

Sale 10b5-1
Shares
220,426
Price
$3.99
Value
$879,500
Open SEC filing

Edwards Carladenise Armbrister

Director

SaleAlert
Shares
67,160
Price
$3.42
Value
$229,687
Open SEC filing

Priest Brady Patrick

CEO of Clover Care Services

SaleAlert
Shares
98,039
Price
$3.52
Value
$345,097
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
5,833
Price
$1.91
Value
$11,141
Open SEC filing

Priest Brady Patrick

CEO of Home Care

SaleAlert
Shares
175,000
Price
$2.17
Value
$379,750
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
4,597
Price
$2.58
Value
$11,860
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
2,102
Price
$2.53
Value
$5,318
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
4,913
Price
$2.61
Value
$12,823
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
30,385
Price
$3.58
Value
$108,778
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
16,514
Price
$2.69
Value
$44,423
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
2,012
Price
$2.65
Value
$5,332
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
4,914
Price
$3.09
Value
$15,184
Open SEC filing

Loengard Anna U

Director

PurchaseAlert
Shares
14,500
Price
$2.59
Value
$37,555
Open SEC filing

Loengard Anna U

Director

PurchaseAlert
Shares
12,000
Price
$2.60
Value
$31,200
Open SEC filing

Garipalli Vivek

Director

PurchaseAlert
Shares
31,980
Price
$2.17
Value
$69,397
Open SEC filing

Garipalli Vivek

Director

PurchaseAlert
Shares
415,000
Price
$2.24
Value
$929,600
Open SEC filing

Reynoso Jamie L.

CEO, Medicare Advantage

Sale 10b5-1
Shares
6,823
Price
$2.89
Value
$19,718
Open SEC filing

Wai Conrad

CEO, Counterpart Health

Sale 10b5-1
Shares
91,197
Price
$3.32
Value
$302,774
Open SEC filing

Wai Conrad

CEO, Counterpart Health

Sale 10b5-1
Shares
118,600
Price
$3.29
Value
$390,194
Open SEC filing

“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.